Evidence map›Paper›PMID 40909396›Full record

ArticleEJHaem2025

Effects of an Electronic Patient Reported Outcome Measures (e-PROMs) Program on Symptom Reporting, Use of Healthcare, and Overall Survival in Patients With Lymphoma: A Multicenter Prospective Study.

Raúl Córdoba, Marta Del Olmo Rodríguez, Sergio Ramos, Alberto López García, Daniel Morillo, Maria-Angeles Pérez-Sáenz, Carolina Miranda, Rafael Martos, Laura Beltrán, Eva Castillo and 5 more

Abstract read
In one paragraph

Article in EJHaem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Raúl CórdobaHaematology Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Marta Del Olmo RodríguezHospital Management Quirónsalud 4-H Network Madrid Spain.
Sergio RamosHaematology Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Alberto López GarcíaHaematology Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Daniel MorilloHaematology Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Maria-Angeles Pérez-SáenzHaematology Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Carolina MirandaHaematology Department Hospital Universitario Rey Juan Carlos Madrid Spain.
Rafael MartosHematology Hospital Universitario General de Villalba Madrid Spain.
Laura BeltránHematology Department Hospital Universitario Infanta Elena Madrid Spain.
Eva CastilloPharmacy Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.
Antonio HerreroInformation Technology and Systems Department Quirónsalud 4-H Network Madrid Spain.
Alvaro Gómez-MeanaInformation Technology and Systems Department Quirónsalud 4-H Network Madrid Spain.
Bernadette PfangPharmacy Department Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.ORCID https://orcid.org/0000-0002-0317-2778
Jorge Short ApellanizHospital Management Quirónsalud 4-H Network Madrid Spain.
Javier Arcos-CampilloHospital Management Hospital Universitario Fundacion Jimenez Diaz Madrid Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Healthcare is shifting from a disease-centered to patient-centered approach, and aspects of health such as quality of life (QoL) are becoming increasingly relevant. "E-Res Salud" for hematological malignancies is a value-based healthcare program aiming to improve patient experience and outcomes. The program collects e-PROMs via automatically deployed, validated questionnaires over a mobile application. Methods: A multicenter prospective observational cohort study including 243 patients with Hodgkin and non-Hodgkin lymphoma receiving outpatient intravenous immunochemotherapy at four teaching hospitals in Madrid, Spain, of whom 121 participated in the "E-Res Salud" program. Results: We found that adverse event reporting differs significantly between patients and healthcare professionals. Participants showed significantly lower rates of emergency department visits (37.2% vs. 56.6%; Conclusions: An e-PROMS program for patients with lymphoma is associated with lower use of healthcare and improved clinical outcomes. Patients and hematologists report adverse events differently, demonstrating the importance of patient-reported outcome measurement to improve symptom management in clinical practice.

Identifiers

PMID40909396
PMCPMC12406075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.